Table 1.
I. Metric | II. Experimental groups | III. Condition | IV. Compiled number of nuclei | V. Number of coverslips | VI. Number of individuals | VII. Test and sample size used |
---|---|---|---|---|---|---|
Density | Patients | Static | 14,629 | 95 | 9 | ANOVA coverslips (column V) |
Stretch | 15,065 | 102 | ||||
Negative Controls | Static | 17,492 | 112 | 10 | ||
Stretch | 16,450 | 118 | ||||
Positive Controls | Static | 5789 | 46 | 1 | ||
Stretch | 5751 | 46 | ||||
Actin OOP | Patients | Static | N/A | 94 | 9 | ANOVA coverslips (column V) |
Stretch | 101 | |||||
Negative Controls | Static | N/A | 112 | 10 | ||
Stretch | 117 | |||||
Positive Controls | Static | N/A | 47 | 1 | ||
Stretch | 47 | |||||
Fibronectin OOP | Patients | Static | N/A | 81 | 9 | ANOVA coverslips (column V) |
Stretch | 88 | |||||
Negative Controls | Static | N/A | 102 | 10 | ||
Stretch | 107 | |||||
Positive Controls | Static | N/A | 41 | 1 | ||
Stretch | 41 | |||||
% Defective nuclei | Patients | Static | 5823 | 94 | 9 | Kruskal–Wallis and Dunn's multiple comparison coverslips (column V) |
Stretch | 5832 | 102 | ||||
Negative Controls | Static | 7687 | 112 | 10 | ||
Stretch | 7595 | 117 | ||||
Positive Controls | Static | 3059 | 46 | 1 | ||
Stretch | 2921 | 46 | ||||
Aspect ratio and area | Patients A | Static | 738 | 33 | 3 | ANOVA nuclei (column IV) and individuals (column VI) |
Stretch | 1012 | 40 | ||||
Patients B | Static | 2445 | 30 | 3 | ||
Stretch | 2480 | 30 | ||||
Patients C | Static | 2640 | 31 | 3 | ||
Stretch | 2340 | 32 | ||||
Negative Controls | Static | 7687 | 112 | 10 | ||
Stretch | 7595 | 117 | ||||
Positive Controls | Static | 3059 | 46 | 1 | ||
Stretch | 2921 | 46 |